Genetically engineered <i>Cdkl5</i> mouse models recapitulate many cognitive, behavioral, and molecular features of CDD, yet their utility is limited by the absence of overt seizures, precluding seizure-based outcome measures. The gene discussed is CDKL5; the disease is craniodiaphyseal dysplasia.